» Articles » PMID: 32851341

Epidemiology and Treatment of Beta Thalassemia Major in China

Overview
Specialty Pediatrics
Date 2020 Aug 28
PMID 32851341
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Thalassemia, classified as the main types α- and β-thalassemia, is a single gene disorder resulting from globin chain synthesis impairment through the mutation or deletion of globin genes. The incidence of thalassemia is high worldwide, with high associated mortality. Therefore, treatment is important to improve patient outcomes. This paper reviews the current status of β-thalassemia major in China, including its epidemiology and treatment.

Citing Articles

Transfusion burden and willingness to pay for temporary alleviation of anemia status in transfusion-dependent beta-thalassemia patients in China.

Chen S, Liu Y, Yin X, Lu Q, Du X, Huang R BMC Health Serv Res. 2024; 24(1):1215.

PMID: 39390469 PMC: 11468025. DOI: 10.1186/s12913-024-11547-2.


Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy.

Chappell M, Breda L, Tricoli L, Guerra A, Jarocha D, Castruccio Castracani C Blood. 2024; 144(15):1633-1645.

PMID: 38949981 PMC: 11487647. DOI: 10.1182/blood.2023023349.


Risk of gout attack not increased in patients with thalassemia: a population-based cohort study.

Chen J, Xu Q, Yang P, Huang J, Cheng-Chung Wei J Sci Rep. 2023; 13(1):2756.

PMID: 36797295 PMC: 9935512. DOI: 10.1038/s41598-023-29709-3.


Spatial and Temporal Expression Characteristics of the Gene Family in Six Different Pig Breeds.

Guo X, Liu Z, Mu Y, Huang L, Li K, Zhang J Genes (Basel). 2022; 13(10).

PMID: 36292707 PMC: 9601290. DOI: 10.3390/genes13101822.


Molecular Spectrum, Ethnic and Geographical Distribution of Thalassemia in the Southern Area of Hainan, China.

Yu Y, Lu C, Gao Y, Li C, Li D, Wang J Front Pediatr. 2022; 10:894444.

PMID: 35783323 PMC: 9245522. DOI: 10.3389/fped.2022.894444.


References
1.
Taher A, Musallam K, Inati A . The hypercoagulable state in thalassemia intermedia. Hemoglobin. 2009; 33 Suppl 1:S160-9. DOI: 10.3109/03630260903351619. View

2.
Ramezanzadeh M, Salehi M, Farajzadegan Z, Kamali S, Salehi R . Detection of paternally inherited fetal point mutations for β-thalassemia in maternal plasma using simple fetal DNA enrichment protocol with or without whole genome amplification: an accuracy assessment. J Matern Fetal Neonatal Med. 2015; 29(16):2645-9. DOI: 10.3109/14767058.2015.1095883. View

3.
Jaing T, Hung I, Yang C, Chen S, Chung H, Tsay P . Unrelated cord blood transplantation for thalassaemia: a single-institution experience of 35 patients. Bone Marrow Transplant. 2011; 47(1):33-9. DOI: 10.1038/bmt.2011.39. View

4.
Xu X, Zhou Y, Luo G, Liao C, Zhou M, Chen P . The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004; 57(5):517-22. PMC: 1770296. DOI: 10.1136/jcp.2003.014456. View

5.
Ma Y, Li J, Gao E, Qian D, Zhong J, Liu C . [Progress of gene editing technologies and prospect in traditional Chinese medicine]. Zhongguo Zhong Yao Za Zhi. 2017; 42(1):34-40. DOI: 10.19540/j.cnki.cjcmm.20161222.003. View